Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank36
3Y CAGR+55.0%
5Y CAGR-19.5%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+55.0%/yr
vs +5.1%/yr prior
5Y CAGR
-19.5%/yr
Recent acceleration
Acceleration
+49.9pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $6.34M | +52.3% |
| 2024 | $4.17M | -56.2% |
| 2023 | $9.50M | +457.7% |
| 2022 | $1.70M | -90.9% |
| 2021 | $18.78M | +0.0% |
| 2020 | $18.77M | +1325.4% |
| 2019 | $1.32M | -5.7% |
| 2018 | $1.40M | -99.5% |
| 2017 | $292.68M | +32.9% |
| 2016 | $220.16M | - |